Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Directorate Change

11 Mar 2024 15:22

RNS Number : 3992G
Schroder UK Mid Cap Fund PLC
11 March 2024

Retirement of Director

As previously disclosed in the Annual Report and Accounts for the year ended 30 September 2023 for Schroder UK Mid Cap Fund plc (the "Company"), Andrew Page did not stand for re-election at the Annual General meeting held on Friday, 8 March 2024 and retired as a director of the Company, in accordance with the Board's succession planning arrangements.

Andrew served on the Board for nine years, the majority of which were as the Chair of the Audit and Risk Committee. Andrew's experienced oversight of financial and internal controls matters, as well as his commitment and dedication to the Company's success were invaluable to the Board during this time, and the Board wishes him well.

Andrew will be succeeded as Chair of the Audit and Risk Committee by Helen Galbraith, as Chair of the Remuneration Committee by Harry Morley, and as Senior Independent Director by Wendy Colquhoun.

Enquiries:

Kathrine Fyfe

Schroder Investment Management Limited

Tel: 020 7658 3136

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOASFFFIFELSEED

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.